201
Views
6
CrossRef citations to date
0
Altmetric
Research Articles

Monoolein-based nanoparticles containing indinavir: a taste-masked drug delivery system

, , , , , , , & show all
Pages 83-91 | Received 14 Apr 2020, Accepted 07 Dec 2020, Published online: 28 Dec 2020

References

  • UNIAIDS . [cited 2020 April 04]. Available from: http://aidsinfo.unaids.org/
  • WHO . 2016. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection.
  • WHO . 2017a. Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy.
  • Chiappetta DA , Carcaboso AM , Bregni C , et al. Indinavir-loaded pH-sensitive microparticles for taste masking: toward extemporaneous pediatric anti HIV/AIDS liquid formulations with improved patient compliance. AAPS PharmSciTech. 2009;10(1):1–6.
  • Schlatter AF , Deathe AR , Vreeman RC. The need for pediatric formulations to treat children with HIV. AIDS Res Treat. 2016;2016:1654938–1654938.
  • Sosnik A , Chiappetta DA , Carcaboso AM. Drug delivery systems in HIV pharmacotherapy: what has been done and the challenges standing ahead. J Control Release. 2009;138(1):2–15.
  • Penazzato M , Palladino C , Sugandhi N , Paediatric ARV Drug Optimization . Prioritizing the most needed formulations to accelerate paediatric antiretroviral therapy scale-up. Curr Opin HIV Aids. 2017;12(4):369–376.
  • Walsh J. Reflection on the pharmaceutical formulation challenges associated with a paediatric investigation plan for an off-patent drug. AAPS PharmSciTech. 2017;18(2):250–256.
  • WHO. 2017b. Guidelines on the public health response to pretreatment HIV drug resistance.
  • Giaretta M , Bianchin MD , Kanis LA , et al. Development of innovative polymer-based matricial nanostructures for ritonavir oral administration. J Nanomater. 2019;2019:1–10.
  • Adhikari P , Pal P , Das AK , et al. Nano lipid-drug conjugate: an integrated review. Int J Pharm. 2017;529(1-2):629–641.
  • Mamo T , Moseman EA , Kolishetti N , et al. Emerging nanotechnology approaches for HIV/AIDS treatment and prevention. Nanomedicine (Lond). 2010;5(2):269–285.
  • Parboosing R , Maguire GE , Govender P , et al. Nanotechnology and the treatment of HIV Infection. Viruses. 2012;4(4):488–520.
  • Grande F , Ioele G , Occhiuzzi MA , et al. Reverse transcriptase inhibitors nanosystems designed for drug stability and controlled delivery. Pharmaceutics. 2019;11(5):197.
  • Cram A , Breitkreutz J , Desset-Brèthes S , European Paediatric Formulation Initiative (EuPFI), et al. Challenges of developing palatable oral paediatric formulations. Int J Pharm. 2009;365(1-2):1–3.
  • Bali V , Ali M , Ali J. Study of surfactant combinations and development of a novel nanoemulsion for minimising variations in bioavailability of ezetimibe. Colloids Surf B Biointerf. 2010;76(2):410–420.
  • Shafiq S , Shakeel F , Talegaonkar S , et al. Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur J Pharm Biopharm. 2007;66(2):227–243.
  • Sharma G , Wilson K , van der Walle CF , et al. Microemulsions for oral delivery of insulin: Design, development and evaluation in streptozotocin induced diabetic rats. Eur J Pharm Biopharm. 2010;76(2):159–169.
  • Abdelkader H , Alani AWG , Alany RG. Recent advances in non-ionic surfactant vesicles (niosomes): self-assembly, fabrication, characterization, drug delivery applications and limitations. Drug Deliv. 2014;21(2):87–100.
  • Basiri L , Rajabzadeh G , Bostan A. α-Tocopherol-loaded niosome prepared by heating method and its release behavior. Food Chem. 2017;221:620–628.
  • Marianecci C , Di Marzio L , Rinaldi F , et al. Niosomes from 80s to present: the state of the art. Adv Colloid Interface Sci. 2014;205:187–206.
  • Yaghmur A , Glatter O. Characterization and potential applications of nanostructured aqueous dispersions. Adv Colloid Interface Sci. 2009;147-148:333–342.
  • Aboud HM , Hassan AH , Ali AA , et al. Novel in situ gelling vaginal sponges of sildenafil citrate-based cubosomes for uterine targeting. Drug Deliv. 2018;25(1):1328–1339.
  • Esposito E , Ravani L , Mariani P , et al. Curcumin containing monoolein aqueous dispersions: a preformulative study. Mater Sci Eng C Mater Biol Appl. 2013;33(8):4923–4934.
  • Peng X , Zhou Y , Han K , et al. Characterization of cubosomes as a targeted and sustained transdermal delivery system for capsaicin. Drug Des Devel Ther. 2015;9:4209–4218.
  • Zhang Y , Huo M , Zhou J , et al. DDSolver: an add-in program for modeling and comparison of drug dissolution profiles. Aaps J. 2010;12(3):263–271.
  • Lagarto A , Vega R , Guerra I , et al. In vitro quantitative determination of ophthalmic irritancy by the chorioallantoic membrane test with trypan blue staining as alternative to eye irritation test. Toxicol in Vitro. 2006;20(5):699–702.
  • Kulkarni CV , Wachter W , Iglesias-Salto G , et al. Monoolein: a magic lipid? Phys Chem Chem Phys. 2011;13(8):3004–3021.
  • Rafique M , Sadaf I , Rafique MS , et al. A review on green synthesis of silver nanoparticles and their applications. Artif Cells Nanomed Biotechnol. 2017;45(7):1272–1291.
  • European Medicines Agency (EMEA) . Committee for Medicinal Products for Human Use (CHMP). Reflection paper: formulations of choice for the paediatric population. 2006.
  • Gamal W , Fahmy RH , Mohamed MI. Development of novel amisulpride-loaded liquid self-nanoemulsifying drug delivery systems via dual tackling of its solubility and intestinal permeability. Drug Dev Ind Pharm. 2017;43(9):1530–1538.
  • Zidan AS , Rahman Z , Khan MA. Product and process understanding of a novel pediatric anti-HIV tenofovir niosomes with a high-pressure homogenizer. Eur J Pharm Sci. 2011;44(1-2):93–102.
  • Kamboj S , Saini V , Bala S. Formulation and characterization of drug loaded nonionic surfactant vesicles (niosomes) for oral bioavailability enhancement. ScientificWorldJournal. 2014;2014(1):959741.
  • Khan MI , Madni A , Peltonen L. Development and in-vitro characterization of sorbitan monolaurate and poloxamer 184 based niosomes for oral delivery of diacerein. Eur J Pharm Sci. 2016;95:88–95.
  • Mohamed MI , Abdelbary AA , Kandil SM , et al. Preparation and evaluation of optimized zolmitriptan niosomal emulgel. Drug Dev Ind Pharm. 2019;45(7):1157–1167.
  • Yeh KC , Deutsch PJ , Haddix H , et al. Single-dose pharmacokinetics of indinavir and the effect of food. Antimicrob Agents Chemother. 1998;42(2):332–338.
  • Wörle G , Siekmann B , Koch MHJ , et al. Transformation of vesicular into cubic nanoparticles by autoclaving of aqueous monoolein/poloxamer dispersions. Eur J Pharm Sci. 2006;27(1):44–53.
  • Patel KK , Kumar P , Thakkar HP. Formulation of niosomal gel for enhanced transdermal lopinavir delivery and its comparative evaluation with ethosomal gel. AAPS PharmSciTech. 2012;13(4):1502–1510.
  • Diaz DA , Colgan ST , Langer CS , et al. Dissolution similarity requirements: how similar or dissimilar are the global regulatory expectations? Aaps J. 2016;18(1):15–22.
  • Khalifa AM , Rasool BKA. Optimized mucoadhesive coated niosomes as a sustained oral delivery system of Famotidine. AAPS PharmSciTech. 2017;18(8):3064–3075.
  • Mahale NB , Thakkar PD , Mali RG , et al. Niosomes: novel sustained release nonionic stable vesicular systems-an overview. Adv Colloid Interface Sci. 2012;183-184:46–54.
  • Soliman MS , Abd-Allah FI , Hussain T , et al. Date seed oil loaded niosomes: development, optimization and anti-inflammatory effect evaluation on rats. Drug Dev Ind Pharm. 2018;44(7):1185–1197.
  • Modi S , Anderson BD. Determination of drug release kinetics from nanoparticles: overcoming pitfalls of the dynamic dialysis method. Mol Pharm. 2013;10(8):3076–3089.
  • Yu M , Yuan W , Li D , et al. Predicting drug release kinetics from nanocarriers inside dialysis bags. J Control Release. 2019;315:23–30.
  • Zeng L , An L , Wu X. Modeling drug-carrier interaction in the drug release from nanocarriers. J Drug Deliv. 2011;2011:370308
  • Scheel J , Hermann M. Integrated risk assessment of a hydroxyapatite-protein-composite for use in oral care products: a weight-of-evidence case study. Regul Toxicol Pharmacol. 2011;59(2):310–323.
  • Sousa GD , Kishishita J , Aquino KAS , et al. Biopharmaceutical assessment and irritation potential of microemulsions and conventional systems containing oil from Syagrus cearensis for topical delivery of amphotericin B using alternative methods. AAPS PharmSciTech. 2017;18(5):1833–1842.
  • Öztürk AA , Yenilmez E , Şenel B , et al. Effect of different molecular weight PLGA on flurbiprofen nanoparticles: formulation, characterization, cytotoxicity, and in vivo anti-inflammatory effect by using HET-CAM assay. Drug Dev Ind Pharm. 2020;46(4):682–695.
  • Scheel J , Kleber M , Kreutz J , et al. Eye irritation potential: usefulness of the HET-CAM under the Globally Harmonized System of classification and labeling of chemicals (GHS). Regul Toxicol Pharmacol. 2011;59(3):471–492.
  • Al-Kasmi B , Al Rahal O , El-Zein H , et al. Structural and in vitro in vivo evaluation for taste masking. Expert Opin Drug Deliv. 2018;15(11):1105–1116.
  • Mennella JA , Mathew PS , Lowenthal ED. Use of adult sensory panel to study individual differences in the palatability of a pediatric HIV treatment drug. Clin Ther. 2017;39(10):2038–2048.
  • Ali AA , Charoo NA , Abdallah DB. Pediatric drug development: formulation considerations. Drug Dev Ind Pharm. 2014; 40(10):1283–1299.
  • Schiffman SS , Zervakis J , Heffron S , et al. Effect of protease inhibitors on the sense of taste. Nutrition. 1999;15(10):767–772.
  • Matsui D. Current issues in pediatric medication adherence. Paediatr Drugs. 2007;9(5):283–288.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.